BlueCrest Capital Management Ltd Makes New $1.36 Million Investment in Arm Holdings PLC Sponsored ADR $ARM

Key Points

• BlueCrest Capital Management acquired 3,832 ARM shares worth approximately $1.36 million during the second quarter. Institutional investors own 7.53% of the company, while CFO Jason Child separately sold 10,400 shares under a pre-arranged Rule 10b5-1 plan.
• ARM reported quarterly revenue of $1.29 billion, up 22.4% year over year, and adjusted earnings of $0.45 per share, exceeding analyst estimates. Wall Street analysts maintain a consensus “Moderate Buy” rating with an average price target of $305.72.
• Arm’s expansion into mobile AI, data centers, robotics and edge computing supports its long-term growth opportunity, but valuation and monetization risks remain; the stock trades at a high price-to-earnings ratio of about 272.

BlueCrest Capital Management Ltd acquired a new stake in Arm Holdings PLC Sponsored ADR (NASDAQ:ARM - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 3,832 shares of the company's stock, valued at approximately $1,359,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Syntax Research Inc. purchased a new position in ARM during the 1st quarter valued at about $30,000. Evelyn Partners Investment Management Services Ltd purchased a new stake in ARM in the 1st quarter worth approximately $30,000. Allied Private Wealth LLC bought a new stake in shares of ARM in the 2nd quarter worth approximately $71,000. FWL Investment Management LLC bought a new stake in shares of ARM in the 2nd quarter worth approximately $34,000. Finally, Cassaday & Co Wealth Management LLC purchased a new position in shares of ARM during the first quarter valued at approximately $40,000. 7.53% of the stock is owned by institutional investors.

Insider Activity

In related news, CFO Jason Child sold 10,400 shares of the stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $255.33, for a total value of $2,655,432.00. Following the completion of the transaction, the chief financial officer directly owned 163,832 shares in the company, valued at $41,831,224.56. This trade represents a 5.97% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Key ARM News

Here are the key news stories impacting ARM this week:

• Positive Sentiment: New mobile platform targets AI and premium gaming growth. Arm unveiled its Mobile Compute Subsystem 2, featuring upgraded CPU cores, AI-focused graphics, neural rendering, ray reconstruction and frame-generation capabilities. The technology could help Arm capture more value from next-generation Android devices and make smartphones capable of more desktop-class gaming and AI workloads. Arm Unveils New CSS for Mobile 2 Platform With AI-Powered Graphics and CPU Upgrades
• Positive Sentiment: Arm is broadening its AI opportunity beyond smartphones. The company previewed compute innovations spanning data centers, edge devices and agentic-AI applications. Its Neoverse CSS N4 reportedly doubles the core ceiling and adds support for LPDDR6 and PCIe Gen 7, potentially improving Arm’s competitiveness in AI servers and infrastructure. Arm Refreshes For Agentic AI Arm Neoverse CSS N4
• Positive Sentiment: Broad partner adoption supports long-term reach. More than 80 partners are involved across Arm’s ecosystem, while the company’s architecture continues to expand into AI, robotics and edge computing. This increases potential licensing and royalty opportunities as customers deploy Arm-based chips in more markets. Arm Extends AI Reach From Data Centers To Edge Devices
• Neutral Sentiment: Management highlighted major future opportunities. CEO Rene Haas said AI could accelerate cancer research and humanoid-robot adoption, but these comments are long-term and do not immediately change revenue or earnings expectations. AI will help find cure for cancer
• Negative Sentiment: Valuation and monetization concerns remain. Arm trades at a demanding valuation, and ecosystem spending or partner adoption does not automatically translate into royalty revenue. Analysts and investors may therefore question whether the company’s growth can justify its premium price. Arm's Rise Hides a $200 Billion Robot Bet
• Negative Sentiment: Industry constraints could delay AI demand. Haas warned that chip shortages and data-center bottlenecks are limiting AI deployment, potentially slowing near-term customer ramps despite strong long-term demand. Arm’s CEO warns chip shortage hampers AI cancer research

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on ARM shares. Sanford C. Bernstein set a $500.00 target price on ARM in a report on Wednesday, June 17th. Weiss Ratings reissued a "hold (c)" rating on shares of ARM in a research report on Friday, July 17th. HSBC lowered shares of ARM from a "buy" rating to a "hold" rating and upped their price objective for the stock from $255.00 to $315.00 in a report on Tuesday, July 14th. Benchmark assumed coverage on shares of ARM in a research report on Thursday, July 16th. They issued a "hold" rating for the company. Finally, Wells Fargo & Company reduced their price target on shares of ARM from $350.00 to $280.00 and set an "overweight" rating on the stock in a research report on Thursday, July 30th. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, ARM currently has a consensus rating of "Moderate Buy" and an average target price of $305.72.

ARM Stock Up 1.0%

NASDAQ ARM opened at $264.23 on Thursday. The firm has a market capitalization of $282.22 billion, a PE ratio of 272.40, a P/E/G ratio of 7.75 and a beta of 3.89. The stock's 50 day moving average is $268.07 and its 200 day moving average is $241.70. Arm Holdings PLC Sponsored ADR has a twelve month low of $100.02 and a twelve month high of $452.70.

ARM (NASDAQ:ARM - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.05. ARM had a return on equity of 12.24% and a net margin of 20.25%.The business had revenue of $1.29 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the prior year, the company earned $0.35 earnings per share. The firm's quarterly revenue was up 22.4% compared to the same quarter last year. On average, research analysts anticipate that Arm Holdings PLC Sponsored ADR will post 1.15 earnings per share for the current year.

ARM Company Profile

Arm Holdings plc is a semiconductor and software intellectual property company headquartered in Cambridge, England. Rather than manufacturing chips, Arm develops processor architectures and technology designs that it licenses to semiconductor companies, device manufacturers and other technology businesses for use in their own products.

Arm's portfolio includes central processing unit (CPU) architectures and processor cores, graphics processing units (GPUs), systems IP, interconnect technology, security solutions and related software and development tools.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.